Researchers from Korea's college of veterinary medicine at Chungnam National University, report that they have created a human vaccine for Type A H1N1 influenza.

According to the Korea Herald, the team, led by professor Seo Sang-heui, reports to have developed the vaccine, which is "not toxic and can be mass-produced." Clinical safety trails will need to be completed, but the likely date that a vaccine could be accessible is sometime in September.
The Centers for Disease Control and Prevention has provided virus samples to researchers globally, including the United States Britain, Japan, Australia and Germany.

"Our team is willing to offer the vaccine free of charge without conditions to research institutions and pharmaceutical firms around the world should they make a request for the sake of the health of humankind," Seo said. The price for one vaccine shot is expected to be around $4.76, he added.